Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ International Journa...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
International Journal of Advanced Research
Article . 2023 . Peer-reviewed
Data sources: Crossref
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

A CASE OF HEADACHE TURNING INTO MYELOPROLIFERATIVE NEOPLASM-A CASE REPORT

Authors: Sreeraj H.;

A CASE OF HEADACHE TURNING INTO MYELOPROLIFERATIVE NEOPLASM-A CASE REPORT

Abstract

Headache is an important clinical symptom commonly encountered by practising physicians. Thorough history and physical examination is a must for arriving at differentials of headache. Headache is divided into-primary and secondary. Myeloproliferative neoplasm induced hyper viscosity and associated headache is an important though a rare entity in clinical medicine. This is the case report of a 60 yr. old female who presented with history of chronic headache which was induced by polycythemia vera, an important myeloproliferative neoplasm. Treatment of MPN associated headache is different from that of normal headache, as it involves treatment of underlying disorder. Main treatment modality involve phlebotomy, cytoreductive therapy-hydroxy urea, low dose aspirin, JAK -1/2 inhibitor-Ruxolitinib. Splenectomy is rarely indicated in present clinical scenario.

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
gold